Science Market Update

Research News: UCLA Stem Cell Study Making a Sensation

Posted by Rebecca Inch-Partridge on Thu, Jan 18, 2018

Most people think of paralysis in terms of not being able to move or walk. But there is another side to being paralyzed , the lack of sensation. The inability to feel pain leaves the person susceptible to burns from inadvertent contact with hot surfaces. Researchers at the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have developed a new protocol which could serve as the first step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.

Read More

Tags: Stem cell research, LAVS, UCLA, laboratory equipment suppliers, Lab Product Sales, research news, UC Los Angeles, BioResearch Product Faire, UCLA research funding, general lab supply, 2017 research funding, nih research funding

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus

UCLA Leading $20M Project to Decrease Growing HIV Infection Rate Among Youths

Posted by Rebecca Partridge on Thu, Aug 10, 2017

“Despite dramatic improvements in the ability to treat and prevent HIV, the HIV rate among youth in America has doubled in the last 10 years,” Mary Jane Rotheram-Borus, director of the Global Center for Children and Families at UCLA stated in a recent article for the UCLA Newsroom. By 2020 the incidence of the disease among youths is expected to increase by 39%. Dr. Rotheram-Boras believes that if acutely infected youths were identified and treated during the period when their infectivity to others is 5-10 fold, then the medical community could reverse this trend and improve the long-term health of youths.  

(Image of UCLA courtesy of Wikimedia

Read More

Tags: LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, NIH grants, UC Los Angeles, BioResearch Product Faire, UCLA research funding, Laboratory product sales, general lab supply, 2017 research funding

UCLA Increasing Cannabis Research With Newly Established Research Group

Posted by Laura Braden on Tue, Aug 08, 2017

As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with such widespread access to cannabis, research if the drug has been limited due to the DEA classifying it as a Schedule I drug in the 1970s. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)

Read More

Tags: University of California Los Angeles, Cannabinoids, LAVS, UCLA, Biotechnology Vendor Showcase Event, 2017, cannabis research

UCLA: Medical Building Reopens After $65M Renovation

Posted by Rebecca Partridge on Thu, Jun 01, 2017

On April 20th UCLA celebrated the grand reopening of the Jules Stein Building after a $65M renovation. This building connects to the Doris Stein Building and the Edie & Lew Wasserman Building to make up the UCLA Stein Eye Institute. Combined, the three buildings provide nearly 300,000 square feet of functional space with over 20 specially equipped laboratories to support vision science investigations.

Read More

Tags: University of California Los Angeles, LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, new medical buildings, BioResearch Product Faire, David Geffen School of Medicine

Funding News: $50M Gift from Mattel to Benefit UCLA Hospital

Posted by Rebecca Partridge on Wed, Apr 26, 2017

In 1998 Mattel’s gift of $25 million made the construction of the UCLA Mattel Children’s Hospital possible. In March 2017 Mattel made a $50M commitment to the UCLA Foundation to expand the hospital’s pediatric services.  Over the last 20 years, Mattel has provided more than $80 million to UCLA’s health care system to support its Children’s Hospital.

(Image of Dr. John Mazziotta, vice chancellor of UCLA Health Sciences and Richard Dickson, president of Mattel, announcing the $50 million gift courtesy of UCLA Newsroom) 

Read More

Tags: LAVS, UCLA, Lab Product Sales, UC Los Angeles, BioResearch Product Faire, 2017 research funding, UCLA hospital

UCLA: Nearly $9M in NHLBI Funding to Help Take Science Solutions to Heart

Posted by Rebecca Partridge on Wed, Mar 15, 2017

Thus far in 2017, the University of California Los Angeles has received over $6.8 million in funding from the National Heart Lung and Blood Institute (NHLBI). This funding has been awarded through multiple grants intended to support cardiovascular research.

Read More

Tags: University of California Los Angeles, cardiovascular research, increase laboratory product sales, UCLA, NIH funding, life science research at UCLA, life science solutions, science solutions, NIH awards 2017

UCLA: Utilizing Patient's Own Cells for Individualized Stem Cell Therapies

Posted by Rebecca Partridge on Wed, Feb 08, 2017

Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.

Read More

Tags: University of California Los Angeles, Stem cell research, Human Stem Cell, UCLA, Stem Cell, biotech vendor show, Biotechnology trade show

UCLA Pioneers New Approach to Coma Treatment

Posted by Rebecca Partridge on Fri, Sep 30, 2016

In a first of its kind study, researchers at UCLA utilized ultrasound to “jump start” the brain of a man with severe brain injury who was recovering from a coma. According to the UCLA Newsroom, the 25 year old man could only perform small, limited movements when instructed and “showed minimal signs of consciousness” before the procedure. Three days after the treatment, he regained full consciousness and language comprehension. He could reliably communicate by shaking or nodding his head.  Five days after, the patient attempted to walk for the first time since the coma.

Read More

Tags: University of California Los Angeles, biomedical research, brain research, UCLA, UCLA research funding, Dana foundation, Tiny Blue Dot Foundation, Dr. Martin Monti

UCLA: One Step Closer to the Cause of Autism

Posted by Rebecca Partridge on Mon, Sep 19, 2016

Over the last 40 years incidence of Autism Spectrum Disorder (ASD) have increased tenfold. Until recently, the cause of autism was a complete mystery. Now a major discovery at UCLA has just brought researchers one step closer to unlocking the mystery of ASD.

The UCLA study found distinctive changes in the levels of tiny regulator molecules known as microRNAs in the brains of people with ASD. These microRNAs control the activities of large gene networks. This finding helps explain why so many genes are abnormal in autism disorders. It could also lead to targeted treatments or preventative measures someday.

Read More

Tags: University of California Los Angeles, Biotech Event, UCLA, biomedical researh, autism research, mircoRNA, Dr. Daniel Geschwind

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News